Eribulin Mesylate

Catalog Number: orb1089624

Catalog Number	orb1089624
Category	Small Molecules
Description	Eribulin is an anticancer drug marketed by Eisai Co. under the trade name Halaven. Eribulin is also known as E7389 and ER-086526, and also carries the US NCI designation NSC-707389. It is used to treat certain patients with breast cancer and liposarcoma.
CAS Number	[441045-17-6]
MW	826.002220000001
SMILES	CS(=O)(O)=O.NC[C@@H](O)C[C@H]1[C@@H](OC)[C@H]2[C@H](C[C@@H]3C(=C)[C@@H](C)C[C@@H](CC[C@H]4C(=C)C[C@@H](O4)CCC56O[C@H]7[C@@H]8[C@@H](O[C@H]7C6)[C@@H](O5)[C@@H]9[C@H](CC[C@H](CC(=O)C2)O9)O8)O3)O1
Formula	C₄₀H₅₉NO₁₁.CH₄O₃S
Note	For research use only
Expiration Date	12 months from date of receipt.

Eribulin mesylate [orb1308822]
Purity:
97.02%
CAS Number:
441045-17-6
MW:
826
Formula:
C₄₁H₆₃NO₁₄S
Sizes Available: 1 mg, 25 mg, 50 mg, 5 mg, 10 mg
Eribulin [orb525558]
CAS Number:
[253128-41-5]
MW:
729.9
Formula:
C₄₀H₅₉NO₁₁
Sizes Available: 10 mg, 100 mg, 25 mg
Eribulin Mesylate 0.5mg [orb1898230]
CAS Number:
441045-17-6
Sizes Available: 10 mg, 1 mg, 0.5 mg, 5 mg